Peramivir

CAS 330600-85-6

In Stock

Peramivir

Cat. No. STUB-API-PERAMIVIRCAS 330600-85-6In Stock

Technical Data

Cat. No.STUB-API-PERAMIVIR

CAS330600-85-6

Mol. FormulaC₁₅H₂₈N₄O₄

Mol. Weight328.413 g/mol

IUPAC(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid

SMILESCCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C

InChIInChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1

InChI KeyXRQDFNLINLXZLB-CKIKVBCHSA-N

Purity—

Description

Overview

Peramivir (trade name Rapivab) is an antiviral drug developed by BioCryst Pharmaceuticals for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. It is approved for intravenous administration

Anant Labs manufacture and furnish high quality Peramivir impurities for global markets. Our Peramivir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.